Mostrar el registro sencillo del ítem

dc.contributor.authorGonzález Andrés, Paula
dc.contributor.authorFernández Peña, Laura
dc.contributor.authorDíez Poza, Carlos 
dc.contributor.authorVillalobos Jorge, Carlos
dc.contributor.authorNúñez Llorente, Lucía 
dc.contributor.authorBarbero Pérez, María Asunción 
dc.date.accessioned2023-06-21T11:07:01Z
dc.date.available2023-06-21T11:07:01Z
dc.date.issued2021
dc.identifier.citationMarine Drugs, 2021, Vol. 19, Nº. 2, 78es
dc.identifier.issn1660-3397es
dc.identifier.urihttps://uvadoc.uva.es/handle/10324/59922
dc.descriptionProducción Científicaes
dc.description.abstractIntracellular Ca2+ plays a pivotal role in the control of a large series of cell functions in all types of cells, from neurotransmitter release and muscle contraction to gene expression, cell proliferation and cell death. Ca2+ is transported through specific channels and transporters in the plasma membrane and subcellular organelles such as the endoplasmic reticulum and mitochondria. Therefore, dysregulation of intracellular Ca2+ homeostasis may lead to cell dysfunction and disease. Accordingly, chemical compounds from natural origin and/or synthesis targeting directly or indirectly these channels and proteins may be of interest for the treatment of cell dysfunction and disease. In this review, we show an overview of a group of marine drugs that, from the structural point of view, contain one or various heterocyclic units in their core structure, and from the biological side, they have a direct influence on the transport of calcium in the cell. The marine compounds covered in this review are divided into three groups, which correspond with their direct biological activity, such as compounds with a direct influence in the calcium channel, compounds with a direct effect on the cytoskeleton and drugs with an effect on cancer cell proliferation. For each target, we describe its bioactive properties and synthetic approaches. The wide variety of chemical structures compiled in this review and their significant medical properties may attract the attention of many different researchers.es
dc.format.mimetypeapplication/pdfes
dc.language.isoenges
dc.publisherMDPIes
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectOrganic chemistryes
dc.subjectDrugses
dc.subjectDrogases
dc.subjectHeterocyclic compoundses
dc.subjectCompuestos heterocíclicoses
dc.subjectPharmacology/Toxicologyes
dc.subjectCalcio en el organismoes
dc.subjectCalcio, Conductos dees
dc.subjectOrganic compounds - Synthesises
dc.subjectCompuestos orgánicos - Síntesises
dc.subjectClinical chemistryes
dc.subjectDrug development
dc.subjectMedicamentos - Investigación
dc.subject.classificationMarine drugses
dc.subject.classificationDrogas marinases
dc.titleMarine heterocyclic compounds that modulate intracellular calcium signals: Chemistry and synthesis approacheses
dc.typeinfo:eu-repo/semantics/articlees
dc.rights.holder© 2021 The authorses
dc.identifier.doi10.3390/md19020078es
dc.relation.publisherversionhttps://www.mdpi.com/1660-3397/19/2/78es
dc.identifier.publicationfirstpage78es
dc.identifier.publicationissue2es
dc.identifier.publicationtitleMarine Drugses
dc.identifier.publicationvolume19es
dc.peerreviewedSIes
dc.description.projectMinisterio de Ciencia e Innovación - (grant RTI2018-099298-B-100)es
dc.description.projectJunta de Castilla y León - (grant VA294-P18)es
dc.identifier.essn1660-3397es
dc.rightsAtribución 4.0 Internacional*
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones
dc.subject.unesco3209 Farmacologíaes
dc.subject.unesco3214 Toxicologíaes


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem